These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 4875370)

  • 41. [On variations of hematic fibrinolytic activity in relation to interventions on the thorax and their prophylactic and therapeutic treatment].
    Spampinato N; Cioce L; Guidone M
    Minerva Anestesiol; 1965 Nov; 31(11):545-7. PubMed ID: 5884432
    [No Abstract]   [Full Text] [Related]  

  • 42. [Fibrinolytic and "consumption" coagulopathy. Therapeutic and clinical remarks].
    Dyk T
    Pol Tyg Lek; 1969 Sep; 24(34):1318-22. PubMed ID: 5308022
    [No Abstract]   [Full Text] [Related]  

  • 43. [Thrombolysis therapy, its use and dosage. I. Theoretical considerations].
    Bosseckert H
    Z Arztl Fortbild (Jena); 1966 Jul; 60(13):777-81. PubMed ID: 4231080
    [No Abstract]   [Full Text] [Related]  

  • 44. [The use of PAMBA in urology].
    Hellinger J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):187-96. PubMed ID: 4174658
    [No Abstract]   [Full Text] [Related]  

  • 45. [Recent aspects of the coagulation process, circumstances for its influencing by drugs].
    Montigel C
    Zentralbl Phlebol; 1968 Feb; 7(1):83-8. PubMed ID: 5682818
    [No Abstract]   [Full Text] [Related]  

  • 46. [Fibrinolytic hemorrhage and antifibrinolytic preparations].
    Panchenko M
    Klin Med (Mosk); 1969 Mar; 47(3):11-7. PubMed ID: 5406805
    [No Abstract]   [Full Text] [Related]  

  • 47. Massive bleeding with fibrinolysis: management with heparin and epsilon aminocaproic acid.
    Bergin JJ; Crosby WH; Jahnke EJ
    Mil Med; 1966 Apr; 131(4):340-4. PubMed ID: 4955920
    [No Abstract]   [Full Text] [Related]  

  • 48. [Coagulo-fibrinolytic system and platelets in cancer--clinical and experimental study on the influence of coagulo-fibrinolytic system and platelets on tumor growth and metastasis].
    Ojiro M
    Igaku Kenkyu; 1983 Mar; 53(2):63-99. PubMed ID: 6375232
    [No Abstract]   [Full Text] [Related]  

  • 49. [The fibrinolytic actiity of urine and its susceptibility to natural and synthetic antifibrinolytic agents].
    Vogel G; Sundermann A; Kresch K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):182-6. PubMed ID: 4174657
    [No Abstract]   [Full Text] [Related]  

  • 50. [Pharmacological aspects of fibrinolysis].
    Prino G; Mantovani M
    Boll Chim Farm; 1969 Nov; 108(11):655-75 contd. PubMed ID: 5378688
    [No Abstract]   [Full Text] [Related]  

  • 51. [Different forms of utilization coagulopathy and their treatment].
    Herschlein HJ; Steichele DF
    Med Welt; 1969 Nov; 44():2389-98. PubMed ID: 4915798
    [No Abstract]   [Full Text] [Related]  

  • 52. [Fibrinolytic diathesis following surgery of the prostate].
    Ambroz W; Kuznik Z; Polubiec A
    Pol Przegl Chir; 1967 Oct; 39(10):Suppl:1098+. PubMed ID: 6080893
    [No Abstract]   [Full Text] [Related]  

  • 53. [Increased fibrinolytic activity in thrombocytopenia and its therapeutic modification by PAMBA].
    Thiele G
    Z Arztl Fortbild (Jena); 1969 Dec; 63(24):1296-8. PubMed ID: 5403440
    [No Abstract]   [Full Text] [Related]  

  • 54. [Advantages and hazards of drug treatment in surgery. Anticoagulants and fibrinolytic agents].
    Gross R
    Chirurg; 1968 May; 39(5):201-8. PubMed ID: 4974339
    [No Abstract]   [Full Text] [Related]  

  • 55. [Evolution in the treatment of fibrinolytic hemorrhage in prostatic surgery].
    Caldarelli GF; Angeletti CA; Esposito R
    Ann Ital Chir; 1967; 43(3):513-26. PubMed ID: 5608283
    [No Abstract]   [Full Text] [Related]  

  • 56. Thrombolysis in extremital arteries--indications and methods.
    Wellander E; Risberg B
    Ann Chir Gynaecol; 1995; 84(4):341-8. PubMed ID: 8687077
    [No Abstract]   [Full Text] [Related]  

  • 57. Determinants of bleeding risk in patients on antithrombotic and antifibrinolytic drugs.
    Meijer K; Schulman S
    Semin Thromb Hemost; 2008 Nov; 34(8):762-71. PubMed ID: 19214914
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Substances inhibiting fibrinolysis].
    Lakin KM; Rachitskaia NG; Gavrilov AP
    Kardiologiia; 1972 Apr; 12(4):139-53. PubMed ID: 4558033
    [No Abstract]   [Full Text] [Related]  

  • 59. [Behavior of plasmatic fibrinolytic activity after adeno-tonsillectomy].
    Conticello S; Lombardo C; Terranova R
    Ann Laringol Otol Rinol Faringol; 1967; 66(3):373-9. PubMed ID: 5632639
    [No Abstract]   [Full Text] [Related]  

  • 60. Antifibrinolytic agents.
    Saber RS
    Va Med Mon (1918); 1966 Nov; 93(11):681-3. PubMed ID: 5957679
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.